Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03281590 · ClinicalTrials.gov registry record
Stroke and Cerebrovascular Diseases Registry
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 4,594
- Enrollment target
NCT03281590 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 4,594 participants.
The verdict
NCT03281590 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 4,594 participants
- Enrollment target
Study Summary
This is a single institutional registry database for the patients with stroke and cerebrovascular diseases. Stroke is the fifth leading cause of death in the United States. Despite extensive research, most of the patients die or suffer from varying degree of post-stroke disabilities due to neurologic deficits. This registry aims to understand the disease and examine the disease dynamics in the local community.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,594 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2022-06-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03281590
The ClinicalTrials.gov registry entry for NCT03281590 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,594 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03281590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03281590 about?
NCT03281590 is a clinical study titled "Stroke and Cerebrovascular Diseases Registry". This is a single institutional registry database for the patients with stroke and cerebrovascular diseases. Stroke is the fifth leading cause of death in the United States. Despite extensive research, most of the patients die or suffer from varying degree of post-stroke disabilities due to neurologi...
What is the current status of trial NCT03281590?
This trial is currently completed. The enrollment target is 4,594 participants. The study started on 2017-09-06. Estimated completion is 2022-06-10.
Who is sponsoring clinical trial NCT03281590?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.